AI Summary
✦ ClarthaValuation Metrics
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
Historical valuation metrics are unavailable for this ticker right now.
Peers & Comparison
Sector: Commodities · Theme: Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
CONTI.NS,0P0001D340,23331 CONTIChemicals | — | — | 25.8x Fair | +5% vs avg | — |
PROLIFE.NS,0P00019KBP,1000 PROLIFEChemicals | — | — | 18.4x Undervalued | -25% vs avg | — |
RCDL.NS,0P0001RQEL,36000 RCDLChemicals | — | — | 6.7x Undervalued | -73% vs avg | — |
ALCODIS ALCODISChemicals | — | — | — | — | — |
ANYA ANYAChemicals | — | — | — | — | — |
BIOPOL BIOPOLChemicals | — | — | — | — | — |
SRF LTD SRFChemicals | +31.8% | 12.7% | 35.4x Premium | +44% vs avg | -10.0% |
AARTI INDUSTRIES LTD AARTIINDChemicals | +42.5% | 5.9% | 36.4x Premium | +49% vs avg | +32.0% |
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
CONTI.NS,0P0001D340,23331 CONTIChemicals | — | — | 25.8x Premium | +52% vs avg | — |
PROLIFE.NS,0P00019KBP,1000 PROLIFEChemicals | — | — | 18.4x Fair | +8% vs avg | — |
RCDL.NS,0P0001RQEL,36000 RCDLChemicals | — | — | 6.7x Undervalued | -61% vs avg | — |
ALCODIS ALCODISChemicals | — | — | — | — | — |
ANYA ANYAChemicals | — | — | — | — | — |
BIOPOL BIOPOLChemicals | — | — | — | — | — |
SHRIAHIMSA SHRIAHIMSAChemicals | — | — | — | — | — |
BALAJIPHOS BALAJIPHOSChemicals | — | — | — | — | — |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹316 CrMar 2026Latest net profit
₹22 CrMar 2026Latest EPS
₹9.10Mar 2026Net margin
12.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales + | 305 | 349 | 190 | 176 | 120 | 260 | 316 |
| Expenses + | 289 | 274 | 139 | 167 | 115 | 245 | 277 |
| Operating Profit | 16 | 76 | 50 | 9 | 4 | 16 | 40 |
| OPM % | 5% | 22% | 26% | 5% | 3.4% | 6% | 12% |
| Other Income + | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Interest | 9 | 5 | 4 | 3 | 4 | 10 | 7 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Profit before tax | 7 | 71 | 46 | 6 | 1 | 4 | 30 |
| Tax % | 31% | 29% | 30% | -34% | 5% | 17% | 25% |
| Net Profit + | 5 | 50 | 32 | 8 | 1 | 3 | 22 |
| EPS in Rs | 1.90 | 19.27 | 13.10 | 3.35 | 0.48 | 1.19 | 9.10 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).